IN2012DN02551A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02551A IN2012DN02551A IN2551DEN2012A IN2012DN02551A IN 2012DN02551 A IN2012DN02551 A IN 2012DN02551A IN 2551DEN2012 A IN2551DEN2012 A IN 2551DEN2012A IN 2012DN02551 A IN2012DN02551 A IN 2012DN02551A
- Authority
- IN
- India
- Prior art keywords
- group
- salt
- derivative
- disclosed
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009227402A JP5325065B2 (ja) | 2009-09-30 | 2009-09-30 | 新規フェノール誘導体 |
| PCT/JP2010/066925 WO2011040449A1 (fr) | 2009-09-30 | 2010-09-29 | Nouveau dérivé de phénol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02551A true IN2012DN02551A (fr) | 2015-08-28 |
Family
ID=43826265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2551DEN2012 IN2012DN02551A (fr) | 2009-09-30 | 2010-09-29 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8367843B2 (fr) |
| EP (1) | EP2484669B1 (fr) |
| JP (1) | JP5325065B2 (fr) |
| KR (1) | KR101647174B1 (fr) |
| CN (1) | CN102639518B (fr) |
| AU (1) | AU2010301675B2 (fr) |
| BR (1) | BR112012007069B1 (fr) |
| CA (1) | CA2775309C (fr) |
| DK (1) | DK2484669T3 (fr) |
| ES (1) | ES2549603T3 (fr) |
| HK (1) | HK1169650A1 (fr) |
| HU (1) | HUE026007T2 (fr) |
| IL (1) | IL218519A (fr) |
| IN (1) | IN2012DN02551A (fr) |
| MX (1) | MX2012003392A (fr) |
| MY (1) | MY160394A (fr) |
| NZ (1) | NZ598582A (fr) |
| PL (1) | PL2484669T3 (fr) |
| PT (1) | PT2484669E (fr) |
| RU (1) | RU2536689C2 (fr) |
| TW (1) | TWI461195B (fr) |
| WO (1) | WO2011040449A1 (fr) |
| ZA (1) | ZA201201895B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5851802B2 (ja) | 2011-03-30 | 2016-02-03 | 富士重工業株式会社 | 炭素繊維強化樹脂複合材用ドリル |
| WO2015191034A1 (fr) * | 2014-06-09 | 2015-12-17 | Baylor College Of Medicine | Inhibiteurs de xanthine oxydase à petites molécules et procédés d'utilisation |
| WO2017038799A1 (fr) * | 2015-09-04 | 2017-03-09 | サントリーホールディングス株式会社 | Inhibiteur de l'activité uréasique |
| CA2998034C (fr) * | 2015-09-10 | 2021-05-04 | Dongfang Shi | Compose pour traiter ou prevenir l'hyperuricemie ou la goutte |
| CN105675557B (zh) * | 2016-01-07 | 2019-01-25 | 济南大学 | 基于苯炔荧光试剂检测硫脲含量的新方法 |
| CA3030821A1 (fr) * | 2016-07-18 | 2018-01-25 | Arthrosi Therapeutics, Inc. | Composes, compositions et methodes de traitement ou de prevention d'un symptome associe a la goutte ou a l'hyperuricemie |
| SG11201909747WA (en) * | 2017-04-28 | 2019-11-28 | Fuji Yakuhin Co Ltd | Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole |
| CN109928890B (zh) * | 2017-12-15 | 2021-11-09 | 重庆常捷医药有限公司 | 一种托伐普坦中间体2-甲基-4-n-(2-甲基苯甲酰)苯甲酸的制备方法 |
| US20230050931A1 (en) * | 2019-12-09 | 2023-02-16 | Fuji Yakuhin Co., Ltd. | Solid pharmaceutical preparation |
| CN111662247A (zh) * | 2020-07-17 | 2020-09-15 | 苏州明锐医药科技有限公司 | 一种多替诺德的合成方法 |
| CN111675675A (zh) * | 2020-07-17 | 2020-09-18 | 苏州明锐医药科技有限公司 | 多替诺德的制备方法 |
| CN112430221B (zh) * | 2020-11-20 | 2023-06-23 | 成都诺和晟泰生物科技有限公司 | 用于预防、治疗或减轻高尿酸血症或痛风的化合物及其应用 |
| WO2022169974A1 (fr) | 2021-02-05 | 2022-08-11 | Nexys Therapeutics, Inc. | Inhibiteurs d'urat1 et utilisations pharmaceutiques associées |
| CN114903879B (zh) * | 2022-06-23 | 2023-10-31 | 东北大学 | 3-烃基苯酚衍生物在制备预防或治疗高脂血症及相关代谢性疾病产品中的用途 |
| CN115160314B (zh) * | 2022-07-28 | 2023-12-05 | 南方医科大学 | 杂环芳酰胺类化合物及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3720683A (en) * | 1970-09-02 | 1973-03-13 | Squibb & Sons Inc | 2-phenyl-3-acylbenzothiazolines and their oxides |
| EP1767531A4 (fr) | 2004-06-10 | 2011-01-05 | Torii Pharmaceutical Co Ltd | Compositions médicinales contenant de la 6-hydroxybenzbromarone ou des sels de celle-ci |
| JP3988832B2 (ja) | 2004-11-29 | 2007-10-10 | 日本たばこ産業株式会社 | 窒素含有縮合環化合物及びその用途 |
| AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| WO2007086504A1 (fr) * | 2006-01-27 | 2007-08-02 | Japan Tobacco Inc. | Acide carboxylique et applications |
| US20080305169A1 (en) * | 2006-05-26 | 2008-12-11 | Japan Tobacco Inc. | Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds |
| US20080064871A1 (en) * | 2006-05-26 | 2008-03-13 | Japan Tobacco Inc. | Production Method of Nitrogen-Containing Fused Ring Compounds |
| WO2008062740A1 (fr) * | 2006-11-20 | 2008-05-29 | Japan Tobacco Inc. | Composé azoté à anneaux fusionnés et son utilisation |
-
2009
- 2009-09-30 JP JP2009227402A patent/JP5325065B2/ja active Active
-
2010
- 2010-09-29 US US13/499,190 patent/US8367843B2/en active Active
- 2010-09-29 HU HUE10820564A patent/HUE026007T2/en unknown
- 2010-09-29 PL PL10820564T patent/PL2484669T3/pl unknown
- 2010-09-29 CA CA2775309A patent/CA2775309C/fr active Active
- 2010-09-29 RU RU2012117786/04A patent/RU2536689C2/ru active
- 2010-09-29 TW TW099132910A patent/TWI461195B/zh active
- 2010-09-29 MY MYPI2012001060A patent/MY160394A/en unknown
- 2010-09-29 IN IN2551DEN2012 patent/IN2012DN02551A/en unknown
- 2010-09-29 AU AU2010301675A patent/AU2010301675B2/en active Active
- 2010-09-29 MX MX2012003392A patent/MX2012003392A/es active IP Right Grant
- 2010-09-29 EP EP10820564.2A patent/EP2484669B1/fr active Active
- 2010-09-29 ES ES10820564.2T patent/ES2549603T3/es active Active
- 2010-09-29 WO PCT/JP2010/066925 patent/WO2011040449A1/fr active Application Filing
- 2010-09-29 KR KR1020127007939A patent/KR101647174B1/ko active IP Right Grant
- 2010-09-29 DK DK10820564.2T patent/DK2484669T3/en active
- 2010-09-29 PT PT108205642T patent/PT2484669E/pt unknown
- 2010-09-29 BR BR112012007069-0A patent/BR112012007069B1/pt active IP Right Grant
- 2010-09-29 NZ NZ598582A patent/NZ598582A/xx unknown
- 2010-09-29 CN CN201080042866.9A patent/CN102639518B/zh active Active
-
2012
- 2012-03-07 IL IL218519A patent/IL218519A/en active IP Right Grant
- 2012-03-14 ZA ZA2012/01895A patent/ZA201201895B/en unknown
- 2012-10-17 HK HK12110248.5A patent/HK1169650A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02551A (fr) | ||
| MY148703A (en) | Polycyclic cinnamide derivatives | |
| MY151003A (en) | Stable pharmaceutical composition comprising a pyrimidine-sulfamide | |
| MY150507A (en) | Polycyclic compound | |
| NZ600840A (en) | Indole compound and pharmaceutical use thereof | |
| IN2014MN02106A (fr) | ||
| RS53617B1 (en) | NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | |
| MX2010006882A (es) | Derivado novedoso de catecol, composición farmaceutica que contiene el mismo, uso del derivado de catecol, y uso de la composición farmaceutica. | |
| TNSN06377A1 (en) | Combinations of glycopyrrolate and beta2 adrenoceptor agonists | |
| MY145328A (en) | New cxcr2 inhibitors | |
| MX340360B (es) | Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas. | |
| MX2009001659A (es) | Compuestos de 2,5-dihidroxibenceno para el tratamiento de rosacea. | |
| RS53807B1 (en) | N- (4 - ((3- (2-AMINO-4-Pyrimidinyl) -2-pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of cancer resistant ANTIMITOTIC AGENCIES | |
| WO2007025880A3 (fr) | Derives de pyrazolone | |
| GEP20125389B (en) | Substituted pyrazole and triazole compounds as ksp inhibitors | |
| MX2010005714A (es) | Compuestos de piridina. | |
| RS52987B (en) | 5- (3,4-Dichloro-phenyl) -N- (2-hydroxy-cyclohexyl) -6- (2,2,2-trifluoroethoxy) -nicotinamide and its salts as agents that raise the HDL cholestrol level | |
| MX2011011716A (es) | Derivados de isoquinolina novedosos. | |
| RS54693B1 (en) | SULFONAMIDES FOR THE PREVENTION OF DIABETES | |
| IN2015DN03869A (fr) | ||
| WO2006109146A3 (fr) | Nouveaux derives heterocycliques | |
| RS53456B (en) | [4 [4- (5-AMINOMETHYL-2-FLUOR-PHENYL) -PIPERIDIN-1-IL] - (1H-Pyrrolo-pyridin-IL) -METHANONE AND THEIR SYNTHESIS | |
| UA105034C2 (uk) | Фармацевтична комбінація 5-фторурацилу і похідного 1,4-дигідропіридину та її застосування в лікуванні раку | |
| NZ599916A (en) | 5-amino-4-hydroxypentoyl amides | |
| UA91054C2 (ru) | Тиофеновые соединения и активаторы рецептора тромбопоэтина |